Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Dividend Growth Split Corp T.DGS

Alternate Symbol(s):  DDWWF | T.DGS.PR.A

The Funds investment objectives are to provide holders of Preferred shares with fixed, cumulative, preferential, quarterly cash distributions and to return the original issue price of 10.00 per Preferred share to shareholders at maturity; and to provide holders of Class A shares with regular monthly cash distributions, targeted to be at least 0.10 per Class A share, and the opportunity for growth in Net Asset Value per Class A share. The Fund invests, on an approximately equally weighted basis, in a portfolio consisting primarily of equity securities of Canadian dividend growth companies. In addition, the Fund may hold up to 20% of the total assets of the portfolio in global dividend growth companies for diversification and improved return potential, at the Managers discretion.


TSX:DGS - Post by User

Comment by mousermanon Oct 11, 2023 3:45pm
114 Views
Post# 35679369

RE:RE:Target closing stores due to theft...

RE:RE:Target closing stores due to theft...
AnEducator wrote: A fascinating consequence of the success of Ozempic as a hunger modulator in reducing weight loss is that Walmart's food sales have ostensibly declined noticeably. Now who would have ever thought of that?

mouserman wrote:

Target is closing nine stores in major cities across four states, claiming theft and organized retail crime have made the environment unsafe for staff and customers – and unsustainable for business.

The big box chain is part of a wave of retailers – both large and small – that say they’re struggling to contain store crimes that have hurt their bottom lines. Many have closed stores or made changes to merchandise and layouts.

Nevertheless, skeptics say stores have not provided enough information to back up their claims, and at least one retailer said theft was an exaggerated issue. 

“We cannot continue operating these stores because theft and organized retail crime are threatening the safety of our team and guests, and contributing to unsustainable business performance,” Target said in a statement. “We know that our stores serve an important role in their communities, but we can only be successful if the working and shopping environment is safe for all.”

It’s not clear that crime is growing significantly more serious. But as economic fears grow amid inflation and rising borrowing costs, shoplifting often comes with the territory, industry watchers say. 

The stores Target plans to close will shut their doors on October 21. The stores include the East Harlem location in New York City, two locations in Seattle, three locations in Portland, and three locations in San Francisco and Oakland.



Read this today, guess it finally out there if its on Reuters.

As Ozempic, Wegovy, and Mounjaro soar in popularity, the drugs are facing increasing scrutiny by regulators over reports of suicidal thoughts.

recent Reuters analysis reveals that over half of the adverse event reports by the U.S. Food and Drug Administration describe suicidal thoughts arising soon after starting or ramping up doses of these injectable drugs.
About 40 percent found relief after quitting the meds or taking a smaller dose.

Popular Drugs Used for Weight Loss Have Been Under Fire Since July

Novo Nordisk’s Ozempic is approved to treat type 2 diabetes, while the company's Wegovy is approved for long-term weight management in obese or overweight adults. Mounjaro, a medication from Eli Lilly, is approved for blood sugar control in adults who have diabetes.

<< Previous
Bullboard Posts
Next >>